Wagner Wealth Management, LLC Immuno Gen, Inc. Transaction History

Wagner Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$3.15 - $5.76 $6,615 - $12,096	2,100 New	2,100 $9,000
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $8,946 - $15,708	-2,100 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $13,650 - $22,113	2,100 New	2,100 $17,000
Q4 2020 Feb 09, 2021	SELL	$3.7 - $7.66 $7,770 - $16,086	-2,100 Closed	0 $0
Q4 2017 Feb 22, 2018	BUY	$5.07 - $7.92 $10,647 - $16,632	2,100	2,100 $16,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Wagner Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wagner Wealth Management, LLC with notifications on news.